{
    "Trade/Device Name(s)": [
        "AspirinWorks\u00ae Test Kit (11-Dehydro Thromboxane B2)"
    ],
    "Submitter Information": "Corgenix, Inc.",
    "510(k) Number": "K062025",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042423"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OBW"
    ],
    "Summary Letter Date": "April 3, 2007",
    "Summary Letter Received Date": "April 4, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.5700"
    ],
    "Regulation Name(s)": [
        "Automated platelet aggregation system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "11-Dehydro Thromboxane B2",
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "96-well microtiter plate"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunoassay (ELISA)",
        "Colorimetric detection"
    ],
    "Methodologies": [
        "Competitive ELISA"
    ],
    "Submission Type(s)": [
        "Test Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for AspirinWorks\u00ae Test Kit ELISA to measure urinary 11-Dehydro Thromboxane B2 for qualitative detection of aspirin effect.",
    "Indications for Use Summary": "Enzyme-linked immunoassay (ELISA) to determine levels of 11-Dehydro Thromboxane B2 in human urine, aiding in qualitative detection of aspirin effect in apparently healthy individuals post ingestion; for professional use in clinical laboratories.",
    "fda_folder": "Hematology"
}